Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Oil for Prevention of Postoperative Nausea and Vomiting
NCT06137027Phase 1Unknown
- Sponsor
- The University of the West Indies
- Start
- Sep 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Cannabidiol Oil with Placebo (2 arms). Primary endpoints: Incidence of Post Operative Vomiting and Incidence of Postoperative Nausea. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06137027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06137027.